AstraZeneca is transitioning 16,000 vehicles in its global fleet to battery-electric assets following the company's move to join the EV100.
AstraZeneca is transitioning 16,000 vehicles in its global fleet to battery-electric assets following the company's move to join the EV100.
The secure and easy all-access connection to your content.
Bookmarked content can then be accessed anytime on all of your logged in devices!
Already a member? Log In